MENU

US Stem Cell Manufacturing Market Projected to Reach $40.40 Billion, Driven by iPSC Adoption and Automated Systems: Market Report

openPR.com USA
Overview
This article summarizes a market research report distributed via openPR.com, predicting substantial growth in the U.S. stem cell manufacturing market, driven by increased iPSC adoption and automated closed system manufacturing. Leading companies like Thermo Fisher, Lonza, and Merck are expanding their portfolios with advanced cell culture media, scalable platforms, and specialized technologies to boost production efficiency and reproducibility in regenerative medicine. Recent expansions into the Asian market are also highlighted.
In Depth

Report Overview

This article provides an overview of a market research report distributed via openPR.com, focusing on the projected growth and key trends within the stem cell manufacturing market in the United States.

Key Research Findings

The U.S. stem cell manufacturing market is predicted to experience significant growth, primarily driven by the increasing adoption of induced pluripotent stem cells (iPSCs) and advancements in automated, closed-system manufacturing technologies. The report highlights that leading companies such as Thermo Fisher Scientific, Lonza, and Merck are actively expanding their portfolios to enhance production efficiency and reproducibility in the field of regenerative medicine. This expansion includes more advanced cell culture media, scalable manufacturing platforms, and specialized technical services. These efforts are crucial for accelerating the commercialization of stem cell-based therapies and broadening patient access. The report also notes that major players are expanding their manufacturing capabilities into the Asian market, indicating a response to increasing global demand.

About the Publisher

The specific publisher of this report is not mentioned, but openPR.com is a press release distribution service commonly used by research firms and corporations to disseminate market research findings. The market data presented is considered to be from a reliable source.

Source: https://www.openpr.com/news/4555178/united-states-stem-cell-manufacturing-market-to-hit-us-40-40

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.

  • Your email and selected fields are used only to deliver the newsletter.
  • We never share your information with third parties.
  • You can unsubscribe anytime via the link in each email.

See our Privacy Policy for details.

Takes about a minute · Unsubscribe anytime

Let's share this post !

Author of this article

Comments

To comment

TOC